HomeTrialNCT04524273
🔬NCT04524273Phase 3ACTIVE NOT RECRUITING

Myasthenia Gravis Inebilizumab Trial

Study Summary

Randomized, double-blind, placebo-controlled, Phase 3, parallel-group study with optional open-label extension.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment238 participants
Primary Completion
Lead SponsorAmgen
Data Retrieved2026-04-13 18:29:34.157077+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.